Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × betrixaban × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1

Interventions

emicizumab 4 voxelotor 1 romiplostim 1 recombinant FVIIa 1 olaparib 1 maltodextrin 1 lusutrombopag 1 luspatercept 1 ibrutinib 1 fludarabine phosphate 1 continuous erythropoietin receptor activator 1 betrixaban 1 anti-inhibitor coagulant complex 1 Rituximab 1 Pharmacogenomic Testing 1 Glutamine 1 Factor VIII 1 Enoxaparin 1 Cyclophosphamide 1 CT-P10 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01583218 2023-08-07

APEX

Alexion Pharmaceuticals, Inc.

Phase 3 Completed

7,513 enrolled 18 charts 1 FDA

Classical hematology

Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡